4-(1-Ethoxyvinyl)-3,3,5,5-tetramethylcyclohexanone
Common Name: |
4-(1-Ethoxyvinyl)-3,3,5,5-tetramethylcyclohexanone |
IUPAC Name: |
4-(1-ethoxyethenyl)-3,3,5,5-tetramethylcyclohexan-1-one |
Molecular Formula: |
C14H24O2 |
SMILES: |
CCOC(=C)C1C(CC(=O)CC1(C)C)(C)C |
Inchi: |
1S/C14H24O2/c1-7-16-10(2)12-13(3,4)8-11(15)9-14(12,5)6/h12H,2,7-9H2,1,3-6H3 |
Inchi Key: |
YLNYLLVKHRZLGO-UHFFFAOYSA-N |
Cas No: |
36306-87-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
224.34 |
Mass (g/mol) |
224.178 |
Molar Refractivity |
67.59 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
286.10 |
Vapor Pressure (mmHg@25.00 °C) |
0.003 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.79 |
LogP |
3.568 |
iLOGP |
2.87 |
XLOGP3 |
3.09 |
WLOGP |
3.57 |
MLOGP |
2.38 |
ESOL Log S |
-2.98 |
ESOL Solubility (mg/ml) |
0.235 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.31 |
Ali Solubility (mg/ml) |
0.11 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-3.72 |
Silicos-IT Solubility (mg/ml) |
0.04 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.47 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.788 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.484 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Warning |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
1 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |